Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENS as Alternative to Nerve Blocks in Chronic Low Back Pain
NCT07273006Phase 4Not yet recruiting
- Sponsor
- Complutense University of Madrid
- Start
- Sep 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in non-specific low back pain (NSLBP) and Facet joint syndrome (FJS) (4 arms), sponsored by Complutense University of Madrid. Primary endpoint: Pain intensity at 7 days. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
non-specific low back pain (NSLBP)Facet joint syndrome (FJS)
Beyond the preview
Go deeper on NCT07273006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07273006.